---
stable_id: R-HSA-9664588
display_name: ERBB2 KD mutants trans-autophosphorylate
species: Homo sapiens
summary: 'The following ERBB2 KD mutants were shown to undergo trans-autophosphorylation
  in the presence of EGFR:<br><br>ERBB2 L755P (Bose et al. 2013);<br>ERBB2 L755S (Kancha
  et al. 2011, Bose et al. 2013);<br>ERBB2 I767M (Bose et al. 2013);<br>ERBB2 D769H
  (Bose et al. 2013);<br>ERBB2 D769Y (Bose et al. 2013);<br>ERBB2 V777L (Kancha et
  al. 2011, Bose et al. 2013);<br>ERBB2 G778_P780dup (Bose et al. 2013, Suzawa et
  al. 2016, Ogoshi et al. 2019);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al.
  2013)<br>ERBB2 V842I (Bose et al. 2013); <br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2
  H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 R896C
  (Bose et al. 2013);ERBB2 Y772_A775dup (Wang et al. 2006)<br><br>The following ERBB2
  KD mutants were shown to undergo trans-autophosphorylation in the presence of ERBB3:<br><br>ERBB2
  L755P (Bose et al. 2013);<br>ERBB2 L755S (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2
  I767M (Ng et al. 2015 – indirect, in response to neuregulin-1 (NRG1) treatment);<br>ERBB2
  D769H (Bose et al. 2013, Collier et al. 2013);<br>ERBB2 D769Y (Bose et al. 2013,
  Collier et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2
  T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2
  T862A (Kancha et al. 2011);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 H878Y
  (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 G776S (Fan
  et al. 2008);<br>ERBB2 Y772_A775dup (Wang et al. 2006)<br><br>In the majority of
  studies, trans-autophosphorylation of specific tyrosine residues of ERBB2 KD mutants
  and its heterodimerization partners, EGFR and ERBB3 (and ERBB4), has not been examined,
  and they are assumed to be identical to tyrosine residues that undergo trans-autophosphorylation
  in the wild type ERBB2 heterodimers. ERBB2 H878Y is also phosphorylated on the substitution
  tyrosine Y878 (Hu, Wan et al. 2015). EGFR and ERBB3 undergo trans-autophosphorylation
  in the presence of ERBB2 L755_T759del mutant, while ERBB2 L755_T759del remains unphosphorylated
  (Bose et al. 2013).<br><br>Phosphorylation at tyrosine Y1221 was demonstrated for
  the following ERBB2 KD mutants:<br>ERBB2 L755S (Trowe et al. 2008);<br>ERBB2 T798I
  (Hanker et al. 2017);<br>ERBB2 L869R (Hanker et al. 2017);<br><br>Phosphorylation
  at tyrosine Y1222 was demonstrated for the following ERBB2 KD mutants:<br>ERBB2
  L755S (Trowe et al. 2008);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 L869R (Hanker
  et al. 2017);<br><br>Phosphorylation at tyrosine Y1248 was demonstrated for the
  following ERBB2 KD mutants:<br>ERBB2 L755S (Croessmann et al. 2019);<br>ERBB2 V777L
  (Croessmann et al. 2019);<br>ERBB2 T798M (Rexer et al. 2013);<br>ERBB2 T798I (Hanker
  et al. 2017);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 Y772_A775dup (Wang et
  al. 2006);<br><br>Phosphorylation of EGFR at tyrosine Y1068 was demonstrated in
  the presence of the following ERBB2 KD mutants:<br>ERBB2 T798M (Rexer et al. 2013);<br>ERBB2
  Y772_A775dup (Wang et al. 2006)<br><br>Phosphorylation of ERBB3 at tyrosine Y1197
  was demonstrated in the presence of the following ERBB2 KD mutants: <br>ERBB2 L755S
  (Croessmann et al. 2019);<br>ERBB2 V777L (Croessmann et al. 2019);<br>ERBB2 T798M
  (Rexer et al. 2013);<br>ERBB2 L869R (Hanker et al. 2017);<br>Phosphorylation of
  ERBB3 at tyrosine Y1289 was demonstrated in the presence of the following ERBB2
  KD mutants:<br>ERBB2 Y772_A775dup (Wang et al. 2006, Minami et al. 2007);<br><br>Trans-autophosphorylation
  of the following ERBB2 KD mutants has not been studied and they are annotated as
  candidates: <br>ERBB2 L755M<br>ERBB2 L755W<br>ERBB2 D769N<br>ERBB2 V777M<br>ERBB2
  V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2 L869Q<br>ERBB2 H878R<br>ERBB2 R896H<br>ERBB2
  G776C<br>ERBB2 G776L<br>ERBB2 G776V'
---

# ERBB2 KD mutants trans-autophosphorylate
**Reactome ID:** [R-HSA-9664588](https://reactome.org/content/detail/R-HSA-9664588)
**Species:** Homo sapiens

## Summary

The following ERBB2 KD mutants were shown to undergo trans-autophosphorylation in the presence of EGFR:<br><br>ERBB2 L755P (Bose et al. 2013);<br>ERBB2 L755S (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 I767M (Bose et al. 2013);<br>ERBB2 D769H (Bose et al. 2013);<br>ERBB2 D769Y (Bose et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 G778_P780dup (Bose et al. 2013, Suzawa et al. 2016, Ogoshi et al. 2019);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013)<br>ERBB2 V842I (Bose et al. 2013); <br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 R896C (Bose et al. 2013);ERBB2 Y772_A775dup (Wang et al. 2006)<br><br>The following ERBB2 KD mutants were shown to undergo trans-autophosphorylation in the presence of ERBB3:<br><br>ERBB2 L755P (Bose et al. 2013);<br>ERBB2 L755S (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 I767M (Ng et al. 2015 – indirect, in response to neuregulin-1 (NRG1) treatment);<br>ERBB2 D769H (Bose et al. 2013, Collier et al. 2013);<br>ERBB2 D769Y (Bose et al. 2013, Collier et al. 2013);<br>ERBB2 V777L (Kancha et al. 2011, Bose et al. 2013);<br>ERBB2 T798M (Kancha et al. 2011, Rexer et al. 2013);<br>ERBB2 V842I (Bose et al. 2013);<br>ERBB2 T862A (Kancha et al. 2011);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 H878Y (Kancha et al. 2011, Hu, Hu et al. 2015, Hu, Wan et al. 2015);<br>ERBB2 G776S (Fan et al. 2008);<br>ERBB2 Y772_A775dup (Wang et al. 2006)<br><br>In the majority of studies, trans-autophosphorylation of specific tyrosine residues of ERBB2 KD mutants and its heterodimerization partners, EGFR and ERBB3 (and ERBB4), has not been examined, and they are assumed to be identical to tyrosine residues that undergo trans-autophosphorylation in the wild type ERBB2 heterodimers. ERBB2 H878Y is also phosphorylated on the substitution tyrosine Y878 (Hu, Wan et al. 2015). EGFR and ERBB3 undergo trans-autophosphorylation in the presence of ERBB2 L755_T759del mutant, while ERBB2 L755_T759del remains unphosphorylated (Bose et al. 2013).<br><br>Phosphorylation at tyrosine Y1221 was demonstrated for the following ERBB2 KD mutants:<br>ERBB2 L755S (Trowe et al. 2008);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 L869R (Hanker et al. 2017);<br><br>Phosphorylation at tyrosine Y1222 was demonstrated for the following ERBB2 KD mutants:<br>ERBB2 L755S (Trowe et al. 2008);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 L869R (Hanker et al. 2017);<br><br>Phosphorylation at tyrosine Y1248 was demonstrated for the following ERBB2 KD mutants:<br>ERBB2 L755S (Croessmann et al. 2019);<br>ERBB2 V777L (Croessmann et al. 2019);<br>ERBB2 T798M (Rexer et al. 2013);<br>ERBB2 T798I (Hanker et al. 2017);<br>ERBB2 L869R (Hanker et al. 2017);<br>ERBB2 Y772_A775dup (Wang et al. 2006);<br><br>Phosphorylation of EGFR at tyrosine Y1068 was demonstrated in the presence of the following ERBB2 KD mutants:<br>ERBB2 T798M (Rexer et al. 2013);<br>ERBB2 Y772_A775dup (Wang et al. 2006)<br><br>Phosphorylation of ERBB3 at tyrosine Y1197 was demonstrated in the presence of the following ERBB2 KD mutants: <br>ERBB2 L755S (Croessmann et al. 2019);<br>ERBB2 V777L (Croessmann et al. 2019);<br>ERBB2 T798M (Rexer et al. 2013);<br>ERBB2 L869R (Hanker et al. 2017);<br>Phosphorylation of ERBB3 at tyrosine Y1289 was demonstrated in the presence of the following ERBB2 KD mutants:<br>ERBB2 Y772_A775dup (Wang et al. 2006, Minami et al. 2007);<br><br>Trans-autophosphorylation of the following ERBB2 KD mutants has not been studied and they are annotated as candidates: <br>ERBB2 L755M<br>ERBB2 L755W<br>ERBB2 D769N<br>ERBB2 V777M<br>ERBB2 V777E<br>ERBB2 T733I<br>ERBB2 V842E<br>ERBB2 L869Q<br>ERBB2 H878R<br>ERBB2 R896H<br>ERBB2 G776C<br>ERBB2 G776L<br>ERBB2 G776V
